BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2014 10:31:00 AM | Browse: 1003 | Download: 944
 |
Received |
|
2013-09-20 10:20 |
 |
Peer-Review Started |
|
2013-09-21 19:53 |
 |
To Make the First Decision |
|
2013-12-12 11:25 |
 |
Return for Revision |
|
2013-12-16 14:27 |
 |
Revised |
|
2013-12-31 13:14 |
 |
Second Decision |
|
2014-01-20 17:15 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-20 18:17 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-02-21 22:00 |
 |
Typeset the Manuscript |
|
2014-03-03 12:25 |
 |
Publish the Manuscript Online |
|
2014-03-06 14:13 |
Category |
Infectious Diseases |
Manuscript Type |
Autobiography |
Article Title |
Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure
|
Manuscript Source |
Invited Manuscript |
All Author List |
Su-Jun Zheng, Shuang Liu, Mei Liu, Malcolm A McCrae, Jun-Feng Li, Yuan-Ping Han, Chun-Hui Xu, Feng Ren, Yu Chen and Zhong-Ping Duan |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Science and Technology Key Project of China |
2012ZX10002004-006 |
National Science and Technology Key Project of China |
2012ZX10004904-003-001 |
National Science and Technology Key Project of China |
2013ZX10002002-006-001 |
Beijing Municipal Science and Technology Commission |
Z131107002213019 |
Beijing Municipal Science and Technology Commission |
Z131100004613030 |
High Technical Personnel Training Program in Beijing Health System |
2011-3-083 |
High Technical Personnel Training Program in Beijing Health System |
2013-3-071 |
Special Scientific Research Fund for Beijing Health Development |
2011-2018-04 |
National Natural Science Foundation of China |
30800979 |
National Natural Science Foundation of China |
30800517 |
|
Corresponding Author |
Yu Chen, PhD, MD, Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, No. 8, Xitou Tiao Road, Youwai Street, Beijing 100069, China. chybeyond@163.com
|
Key Words |
Acute-on-chronic liver failure; Chronic hepatitis B virus infection; Liver disease stage; Liver disease severity; Serum M65 level; Serum M30 level; Prognostic value |
Core Tip |
Massive hepatic cell death is a key characteristic of liver failure. Enzyme-linked immunosorbent assay was used to measure M65 and M30 in a chronic hepatitis B (CHB) infection cohort which included healthy controls, CHB and acute-on-chronic liver failure (ACLF) patients. Elevated M65 and M30 differentiated CHB or ACLF patients from healthy controls and gradually increased with disease severity. M30/M65 was significantly increased in ACLF patients with spontaneous recovery (P = 0.032), and the AUC of this ratio at the 3-mo survival period was 0.661 (sensitivity: 52.9%) with a high specificity (92.6%) compared with the Model for End-Stage Liver Disease and Child-Pugh scores. |
Publish Date |
2014-03-06 14:13 |
Citation |
Zheng SJ, Liu S, Liu M, McCrae MA, Li JF, Han YP, Xu CH, Ren F, Chen Y, Duan ZP. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2014; 20(9): 2403-2411 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i9/2403.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i9.2403 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345